Europe approves Biocon's Rosuvastatin Calcium tablets

The approval in the regulated markets marks an important milestone in Biocon's small molecules strategy of forward integration from APIs.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news